Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Cannabis Pharmaceuticals Market Growth in 2025?

The size of the pharmaceutical cannabis market has experienced rapid expansion in the recent past. This growth is forecasted to leap from $6.03 billion in 2024 to a whopping $9.45 billion in 2025, with a compound annual growth rate (CAGR) of 56.66%. The substantial growth witnessed in the historical period is due to several factors including heightened legalization of medicinal cannabis, increased awareness of the therapeutic benefits of cannabinoids, escalating incidences of chronic and neurological conditions, favorable regulations, significant investment by pharmaceutical companies, and a shifting public opinion regarding the use of cannabis in the healthcare sector.

What Is the Forecast for the Cannabis Pharmaceuticals Market Size Through 2029?

Over the coming years, the cannabis pharmaceuticals market is projected to undergo sizeable expansion. By 2029, it is forecasted to reach a valuation of $56.37 billion, achieving a compound annual growth rate (CAGR) of 56.29%. The projected growth throughout this period can be linked to various factors such as increased regulatory approval, heightened public awareness of the health benefits of medical cannabis, the application of cannabis in treating pain and neurological disorders, a rise in chronic illnesses, advancement in drug delivery systems, and the formulation of beneficial reimbursement policies. The period is also likely to witness trends like progress in cannabinoid extraction technologies, creation of targeted drug delivery systems, preference for synthetic cannabinoid formulations, enhancement of clinical trial methods, and the incorporation of artificial intelligence in drug discovery.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20723&type=smp

What are the Key Market Players in Cannabis Pharmaceuticals Market and How They’re Evolving?

Major companies operating in the cannabis pharmaceuticals market are Curaleaf Holdings Inc., Aphria Inc., Green Thumb Industries Inc., Trulieve Cannabis Corp., Tilray Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc., Canopy Growth Corporation, Aurora Cannabis Inc., MedMen Enterprises Inc., OrganiGram Holdings Inc., Cronos Group, Enveric Biosciences Inc., Auxly Cannabis Group Inc., Valens Company Inc., Charlotte’s Web Holdings Inc., Medical Marijuana Inc., Aleafia Health Inc., Supreme Cannabis Company Inc., Avicanna Inc., Emerald Health Therapeutics Inc.

What Are the Primary Growth Drivers in the Cannabis Pharmaceuticals Market?

The growth of the cannabis pharmaceuticals market is largely due to the increasing prevalence of epilepsy. Epilepsy, a neurological condition marked by frequent, unprovoked seizures resulting from abnormal brain electrical activity, is becoming more common. This increase is due to improved detection, heightened awareness, and more thorough reporting, in addition to likely environmental, genetic, and lifestyle factors. Cannabis pharmaceuticals, particularly cannabinoids like CBD, have shown promise in controlling epilepsy, lowering the frequency and intensity of seizures in patients who do not see benefits from typical anti-epileptic medicines. For example, the Belgium-based non-profit European Brain Council reported in April 2022 that over 600 neurological diseases and about 300 psychiatric conditions affect millions worldwide, 65 million of which suffer from epilepsy. Furthermore, the Alzheimer Society of Canada, a Canadian health charity, estimated in July 2024 that by January 1, 2025, 771,939 Canadians will be diagnosed with dementia, with this number expected to approach one million by 2030. Therefore, the escalating incidence of epilepsy is propelling the expansion of the cannabis pharmaceuticals market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20723&type=smp

What Are the Leading Segments in the Global Cannabis Pharmaceuticals Industry?

The cannabis pharmaceuticals market covered in this report is segmented –

1) By Product Type: Cannabinoid-Based Pharmaceuticals, Cannabis Extracts, Synthetic Cannabinoids

2) By Formulation Type: Capsules And Tablets, Oils And Tinctures, Topical Solutions

3) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management

4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

5) By End-User: Hospitals And Clinics, Rehabilitation Centers, Research Organizations

Subsegments:

1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations

2) By Cannabis Extracts: Full-Spectrum Cannabis Extracts, Broad-Spectrum Cannabis Extracts, Isolate Cannabis Extracts (CBD Isolate)

3) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists, Designer Synthetic Cannabinoids

What Are the Key Market Trends in the Cannabis Pharmaceuticals Industry?

Significant players in the medical cannabis market, like Canexis Pharma AG, are concentrating their efforts on the creation of novel products such as advanced medical cannabis formulations. These products are specially engineered for therapeutic use and utilize precise measures of cannabinoids such as THC and CBD to address various medical conditions and boost patient outcomes. For instance, in April 2024, Canexis, a Swiss pharmaceutical firm, was granted manufacturing and narcotic licenses from Swissmedic to carry out cannabis pharmaceuticals production. The licensing enables the company to generate premium-grade medicinal components from CBD and THC. The accreditation not only strengthens Canexis’s reliability and compliance with stringent regulatory norms but also positions it to meet the increasing global demand for medical cannabis in Switzerland and around the world.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cannabis-pharmaceuticals-global-market-report

What Is the Regional Outlook for the Cannabis Pharmaceuticals Market?

North America was the largest region in the cannabis pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20723

This Report Delivers Insight On:

1. How big is the cannabis pharmaceuticals market, and how is it changing globally?

2. Who are the major companies in the cannabis pharmaceuticals market, and how are they performing?

3. What are the key opportunities and risks in the cannabis pharmaceuticals market right now?

4. Which products or customer segments are growing the most in the cannabis pharmaceuticals market?

5. What factors are helping or slowing down the growth of the cannabis pharmaceuticals market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model